Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Tumor Necrosis Factor-α Contributes to Microenvironmental up- Regulation of NF-κB Activity in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Implication for a Novel Therapeutic Target.

Hui-Jen Tsai, MD, Seiichiro Kobayashi, MD, PhD, Kiyoko Itoh, PhD, Takaomi Ishida, PhD, Kazuo Umezawa, PhD, Arinobu Tojo, MD, PhD

Blood (2008) 112 (11): 1912.

https://doi.org/10.1182/blood.V112.11.1912.1912

Published: 2008

Journal Articles

Molecular Allelo-Karyotyping of Adult T-Cell Leukemia Using High SNP Genotyping Microarrays.

Satsuki Muto, Go Yamamoto, M.D., Ph.D., Yasuhito Nannya, M.D., Ph.D, Masashi Sanada, M.D., Nazanin Dabaghmanesh, M.D., Takaomi Ishida, Ph.D., Atae Utsunomiya, M.D., Ph.D., Yasuaki Yamada, M.D., Ph.D, Shimeru Kamihira, M.D., Ph.D, Kazunari Yamaguchi, M.D., Ph.D, Toshiki Watanabe, M.D., Ph.D, Seishi Ogawa, M.D., Ph.D

Blood (2007) 110 (11): 2385.

https://doi.org/10.1182/blood.V110.11.2385.2385

Published: 2007

Journal Articles

Activation of Nuclear Factor KappaB in ETV6/FLT3-Transformed Ba/F3 Cells Depends on the FLT3 Tyrosine 591.

Hoang Anh Vu, MD, PhD, Phan Thi Xinh, M.D., Ph.D., Yasuhiko Kano, M.D., Ph.D., Takaomi Ishida, Ph.D, Toshiki Watanabe, M.D., Ph.D., Katsushi Tokunaga, Ph.D., Yuko Sato, M.D., Ph.D.

Blood (2007) 110 (11): 4666.

https://doi.org/10.1182/blood.V110.11.4666.4666

Published: 2007

Journal Articles

Microenvironmental Up-Regulation of NF-kB Activity Via P65-Dependent and Independent Pathways in a Bioimaging Model of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Hui-Jen Tsai, MD, Seiichiro Kobayashi, M.D., Ph.D., Kiyoko Itoh, Ph.D., Takaomi Ishida, Ph.D., Kazuo Umezawa, Ph.D., Arinobu Tojo, M.D., Ph.D.

Blood (2007) 110 (11): 723.

https://doi.org/10.1182/blood.V110.11.723.723

Published: 2007

Journal Articles

Dual targeting of transformed and untransformed HTLV-1–infected T cells by DHMEQ, a potent and selective inhibitor of NF-κB, as a strategy for chemoprevention and therapy of adult T-cell leukemia

Mariko Watanabe, Takeo Ohsugi, Momoko Shoda, Takaomi Ishida, Shigemi Aizawa, Masae Maruyama-Nagai, Atae Utsunomiya, Shin Koga, Yasuaki Yamada, Shimeru Kamihira, Akihiko Okayama, Hiroshi Kikuchi, Kimiharu Uozumi, Kazunari Yamaguchi, Masaaki Higashihara, Kazuo Umezawa, Toshiki Watanabe, Ryouichi Horie

Blood (2005) 106 (7): 2462–2471.

https://doi.org/10.1182/blood-2004-09-3646

Published: 2005

Includes: Supplemental data

NARROW

Tumor Necrosis Factor-α Contributes to Microenvironmental up- Regulation of NF-κB Activity in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Implication for a Novel Therapeutic Target.

Molecular Allelo-Karyotyping of Adult T-Cell Leukemia Using High SNP Genotyping Microarrays.

Activation of Nuclear Factor KappaB in ETV6/FLT3-Transformed Ba/F3 Cells Depends on the FLT3 Tyrosine 591.

Microenvironmental Up-Regulation of NF-kB Activity Via P65-Dependent and Independent Pathways in a Bioimaging Model of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Dual targeting of transformed and untransformed HTLV-1–infected T cells by DHMEQ, a potent and selective inhibitor of NF-κB, as a strategy for chemoprevention and therapy of adult T-cell leukemia

Email alerts

ASH Publications

American Society of Hematology

Tumor Necrosis Factor-α Contributes to Microenvironmental up- Regulation of NF-κB Activity in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Implication for a Novel Therapeutic Target.

Molecular Allelo-Karyotyping of Adult T-Cell Leukemia Using High SNP Genotyping Microarrays.

Activation of Nuclear Factor KappaB in ETV6/FLT3-Transformed Ba/F3 Cells Depends on the FLT3 Tyrosine 591.

Microenvironmental Up-Regulation of NF-kB Activity Via P65-Dependent and Independent Pathways in a Bioimaging Model of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Dual targeting of transformed and untransformed HTLV-1–infected T cells by DHMEQ, a potent and selective inhibitor of NF-κB, as a strategy for chemoprevention and therapy of adult T-cell leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only